Yueli Wang

Shihezi, 832003, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

A Meta-Analysis of the Protective Efficacy of Brucella abortus S2308 Gene-Deletion Mutant Vaccines Compared to Conventional Vaccines in Mice.

A Meta-Analysis of the Protective Efficacy of Brucella abortus S2308 Gene-Deletion Mutant Vaccines Compared to Conventional Vaccines in Mice.

Journal: Microorganisms
Published: May 18, 2026

Immunogenicity and post-challenge virological outcomes of a multivalent subunit vaccine in sheep challenged with cytopathic BVDV-1a.

Immunogenicity and post-challenge virological outcomes of a multivalent subunit vaccine in sheep challenged with cytopathic BVDV-1a.

Journal: Veterinary microbiology
Published: April 22, 2026

Brucella proline racemase protein A targets Tpl2 to promote IL-10 secretion for establishment of chronic infection.

Brucella proline racemase protein A targets Tpl2 to promote IL-10 secretion for establishment of chronic infection.

Journal: Frontiers in immunology
Published: February 10, 2026

Cross-protective immunity elicited by heterologous DNA prime/subunit or adenovirus boost regimens against bovine viral diarrhea virus.

Cross-protective immunity elicited by heterologous DNA prime/subunit or adenovirus boost regimens against bovine viral diarrhea virus.

Journal: BMC veterinary research
Published: December 12, 2025

Brucella-infected macrophage-derived microparticles enhance the host anti-Brucella acquired immune response.

Brucella-infected macrophage-derived microparticles enhance the host anti-Brucella acquired immune response.

Journal: Veterinary microbiology
Published: June 14, 2025

Brucella-infected macrophage-derived Exosomes enhance the anti-Brucella acquired immune response.

Brucella-infected macrophage-derived Exosomes enhance the anti-Brucella acquired immune response.

Journal: International immunopharmacology
Published: June 13, 2025

A BtpB-Deleted Brucella Vaccine Strain Provides Dual Advantages: Enhanced Protection and Diagnostic Differentiation Capability in Mice.

A BtpB-Deleted Brucella Vaccine Strain Provides Dual Advantages: Enhanced Protection and Diagnostic Differentiation Capability in Mice.

Journal: Microbial biotechnology
Published: June 10, 2025

A novel IgG-Fc-Fused multiepitope vaccine against Brucella: robust immunogenicity.

A novel IgG-Fc-Fused multiepitope vaccine against Brucella: robust immunogenicity.

Journal: Microbial cell factories
Published: January 22, 2025

Genome and Pathogenicity Analysis of an NADC30-like PRRSV Strain in China's Xinjiang Province.

Genome and Pathogenicity Analysis of an NADC30-like PRRSV Strain in China's Xinjiang Province.

Journal: Viruses
Published: January 08, 2025

Evaluation of the safety and immune protection of OMPAC, PAPF, and EBPSs recombinant subunit vaccines Developed for Escherichia coli, Staphylococcus aureus, and Streptococcus agalactiae in mice.

Evaluation of the safety and immune protection of OMPAC, PAPF, and EBPSs recombinant subunit vaccines Developed for Escherichia coli, Staphylococcus aureus, and Streptococcus agalactiae in mice.

Journal: International immunopharmacology
Published: July 12, 2024

A multi-epitope subunit vaccine based on CU/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB/C mice.

A multi-epitope subunit vaccine based on CU/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB/C mice.

Journal: International immunopharmacology
Published: October 09, 2023

Design of a multi-epitope vaccine against brucellosis fused to IgG-fc by an immunoinformatics approach.

Design of a multi-epitope vaccine against brucellosis fused to IgG-fc by an immunoinformatics approach.

Journal: Frontiers in veterinary science
Published: June 12, 2023
Showing 1-12 of 24

Last Updated: 09/26/2026